Anttila M, Eskola J, Ahman H, Käyhty H
Department of Vaccines, National Public Health Institute, Helsinki, Finland.
Vaccine. 1999 Apr 9;17(15-16):1970-7. doi: 10.1016/s0264-410x(98)00458-7.
Avidity of antibodies to Streptococcus pneumoniae type 6B, 14, 19F and 23F polysaccharides (PS) evoked by four different pneumococcal conjugate vaccines was compared. Infants were primed with pneumococcal PS conjugated to the variant diphtheria toxin CRM197 (PncCRM), diphtheria toxoid (PncD), tetanus toxoid (PncT) or meningococcal protein complex (PncOMPC) and boosted with the homologous conjugate or PS vaccine. No booster was given to children in the PncOMPC group. Relative antibody avidity was measured by thiocyanate EIA. No vaccine specific differences were found in avidity of anti-14 or -19F antibodies. By contrast, antibody avidity to 6B and 23F differed significantly between the vaccine groups, PncCRM and PncT inducing antibodies of highest avidity.
比较了四种不同的肺炎球菌结合疫苗诱发的针对6B、14、19F和23F型肺炎链球菌多糖(PS)抗体的亲和力。婴儿先用与变异白喉毒素CRM197(PncCRM)、白喉类毒素(PncD)、破伤风类毒素(PncT)或脑膜炎球菌蛋白复合物(PncOMPC)结合的肺炎球菌PS进行初次免疫,然后用同源结合疫苗或PS疫苗进行加强免疫。PncOMPC组儿童未给予加强免疫。通过硫氰酸盐酶免疫测定法测量相对抗体亲和力。在抗14或抗19F抗体的亲和力方面未发现疫苗特异性差异。相比之下,疫苗组之间针对6B和23F的抗体亲和力存在显著差异,PncCRM和PncT诱导的抗体亲和力最高。